Acurx Pharmaceuticals
ACXP
ACXP
18 hedge funds and large institutions have $345K invested in Acurx Pharmaceuticals in 2025 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 3 increasing their positions, 5 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more ownership
Funds ownership: →
40% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 5
Holders
18
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$199K | |
| 2 | +$112K | |
| 3 | +$81.1K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$59.5K |
| 5 |
Jane Street
New York
|
+$51.5K |
Top Sellers
| 1 | -$72.1K | |
| 2 | -$37.3K | |
| 3 | -$37K | |
| 4 |
GWSG
GPS Wealth Strategies Group
Centennial,
Colorado
|
-$5.26K |
| 5 |
Citigroup
New York
|
-$2.17K |
